Human immunodeficiency virus-associated sensory neuropathy (HIV-SN) remains a frequent neurologic complication of HIV infection. Little is known about alterations in the peripheral nervous system during the early stages of HIV, a time when neuroprotective interventions may be most beneficial. We performed Nanostring gene expression analysis on lumbar dorsal root ganglia (DRG) from 6 simian immunodeficiency virus (SIV)-infected pigtailed macaques killed at 7 days post-inoculation and 8 uninfected controls. We found significant upregulation of many genes involved in immune signaling and activation in the DRG. Among genes related to glutamate metabolism, there was significant upregulation of glutamine synthetase (GS), while glutaminase (GLS) was downregulated. Several genes involved in the oxidative stress response also showed significant differential regulation in the DRG of 7d SIV-infected animals, with superoxide dismutase-2 (SOD2) showing the greatest median fold change compared to controls. Novel findings in the DRG were compared to corresponding brain data and further investigated at the protein level by Western blotting and immunohistochemistry. Together with our previous finding of significant epidermal nerve fiber loss at 14 days post-SIV infection, results of this study demonstrate that immune activation and altered cellular metabolism at in the DRG precede and likely contribute to early sensory nerve injury in HIV-SN.
INTRODUCTION
Human immunodeficiency virus-associated sensory neuropathy (HIV-SN) continues to be a frequent and challenging neurologic complication of HIV infection despite widespread use of modern combination antiretroviral therapy (cART) (1) (2) (3) (4) . Patients with HIV-SN typically present with numbness, parestethias, and pain most severely affecting the distal extremities (5-7). Although HIV-SN is not a lifethreatening condition, the painful symptoms are often poorly responsive to existing analgesic medications and can negatively impact patients' quality of life (8) (9) (10) (11) (12) . Lack of effective treatment stems from our incomplete understanding of the mechanisms underlying sensory nerve injury in the context of HIV infection. While autopsy studies have demonstrated increased amounts of viral proteins and inflammatory mediators in the dorsal root ganglia (DRG) and spinal cord of HIV patients (13) (14) (15) (16) (17) , such reports have been limited to patients with late-stage disease.
Efforts to explain the continued high prevalence of human immunodeficiency virus HIV-associated neurologic disorders in patients on cART are increasingly focused on the early stages of infection. Several clinical studies have shown compelling evidence that central nervous system (CNS) immune activation, neuronal injury, and cognitive dysfunction arise early during the course of infection in many individuals (18) (19) (20) . Similarly, a recent study by Wang and colleagues found that, among a cohort of patients with primary HIV infection (defined as <1 year after transmission), 35% of individuals had signs of sensory neuropathy (SN) and 20% were symptomatic for SN (21) . They also demonstrated that the occurrence of SN in this cohort was associated with elevated markers of immune activation in the plasma and cerebrospinal fluid (CSF), suggesting that SN during early HIV infection may be mediated by systemic and nervous system immune responses. Importantly, this group underwent detailed neurologic evaluation prior to the initiation of cART, which itself can cause antiretroviral toxic neuropathy, a condition that is clinically indistinguishable from HIV-mediated SN, and often confounds studies of SN in HIV patients.
Similar to these findings in primary HIV patients, previous studies by our group and others have demonstrated alterations in the peripheral nervous system (PNS) of simian immunodeficiency virus (SIV)-infected macaques at early time points in the course of disease. A 2007 study by Laast et al showed that SIV RNA was detectable by in situ hybridization in the trigeminal ganglia of pigtailed macaques (Macaca nemestrina) killed during acute and asymptomatic stages of infection (22) . Subsequent studies focusing on the lumbar DRG, which contain the cell bodies of sensory neurons that innervate the lower limbs, demonstrated significantly increased amounts of CD68 immunostaining in the DRG of animals at 10 days post-infection (dpi), followed by significant decline in epidermal nerve fiber density (ENFD) at 14 dpi (23) . This suggested that inflammation in the DRG during acute infection might contribute to early sensory nerve injury and die-back of distal axons. ENFD decline has also been observed in CD8-depleted rhesus macaques (Macaca mulatta) as early as 8-21 dpi with SIVmac251 (24) . In addition, significant loss of ENFD persisted in a group of cART-treated pigtailed macaques despite initiation of therapy at 12 dpi (23), further highlighting the potential importance of early sensory nerve damage in the development of HIV-SN.
The observation that CD68 immunostaining increases in the DRG during acute SIV infection and precedes significant losses of ENFD supports the premise that macrophagemediated inflammation in the DRG contributes to early sensory nerve injury and degeneration of distal axons. However, while increased CD68 immunostaining is an often-used indicator of macrophage activation, it is a relatively nonspecific marker and provides little information regarding the molecular processes leading to or resulting from this activation state. In an effort to guide and inform future studies of neuroprotective strategies in HIV patients, the goals of this study were to gain a more detailed understanding of the immune responses occurring within the DRG during acute SIV infection and to identify potential mechanisms underlying early sensory nerve injury. We performed RNA and protein isolation on lumbar DRG collected from uninfected macaques, as well as SIV-infected animals killed at 7 dpi-the acute time point at or close to peak plasma and CSF viral loads following SIV inoculation in our model (25) . RNA was used for Nanostring nCounter gene expression analysis, a technology that allows for the quantification of a large number of mRNA transcripts without reverse transcription or DNA amplification (26, 27) . From the Nanostring panel, we focused on genes related to proinflammatory immune activation and antiviral responses as well as genes involved in glutamate metabolism and oxidative stress, 2 pathways that have been strongly implicated in the pathogenesis of neuronal injury during HIV-associated neurocognitive disease (HAND) (28) (29) (30) (31) (32) . Significant novel findings from the gene expression analysis were further validated at the protein level by Western blot using lumbar DRG homogenates and immunohistochemistry on fixed tissue sections.
MATERIALS AND METHODS

Animals
Six juvenile male pigtailed macaques were intravenously dual-inoculated with the neurovirulent clone SIV/17E-Fr and the immunosuppressive swarm SIV/DeltaB670 as previously described in (33) and killed at day 7 post-infection (from here on referred to as 7d SIV-infected animals). Eight uninfected pigtailed macaques served as controls and were killed at 12 weeks following sham inoculation. At the time of necropsy, animals were whole-body saline perfused to remove blood from tissue vasculature. PNS tissues were dissected and either snap frozen and stored at À80 C until use or fixed in Streck tissue fixative (Streck Laboratories, Omaha, NE) and embedded in paraffin. All animal procedures in this study were conducted with the approval of the Johns Hopkins University Institutional Animal Care and Use Committee and the National Research Council's Guide for the Care and Use of Laboratory Animals (8th Edition).
RNA Isolation and Gene Expression Analysis
Total RNA was isolated from frozen L3 DRG by first extracting with RNA-Stat 60 (Tel-Test, Inc., Alvin, TX) and chloroform, followed by purification using the RNeasy kit (Qiagen, Frederick, MD) according to the manufacturer's protocol, with the inclusion of on-column genomic DNA removal using the RNase-Free DNAse Set (Qiagen). RNA concentration and purity were measured using a Nanodrop Spectrophotometer (Thermo Fisher Scientific, Waltham, MA).
A total of 100 ng of RNA per sample was used for nCounter Gene Expression Assay (Nanostring Technologies, Seattle, WA), which was performed according to the manufacturer's protocol by the Johns Hopkins Deep Sequencing and Microarray Core Facility. The assay made use of a custom Nanostring Codeset designed to measure 249 transcripts of interest and 11 putative housekeeping transcripts based on rhesus macaque (Macaca mulata) and human sequences. For the purpose of this study, analysis was focused on a total of 112 genes involved in immune signaling and activation, glutamate metabolism, the oxidative stress response, and neuronal damage. To account for probe-specific background, 100 ng of MS2 phage RNA (Roche, Basel, Switzerland) was run in duplicate as a negative control.
Nanostring data were analyzed as previously described in (34, 35) by first adding a value of 1 to all counts (to exclude any zero values), normalizing to the geometric mean of manufacturer spike-in controls, and normalizing to the geometric mean of the three housekeeping genes that were most stably expressed in the DRG between animal groups (HMBS, SDHA, and TBP). Data are reported as normalized transcript counts. The lower limit of detection for each probe was set to the mean value for the MS2 phage RNA control þ2 standard deviations. Genes that had more than 1 value falling below the limit of detection were excluded from analyses (12 out of 112 genes of interest were excluded on this basis).
To compare gene expression changes in the PNS to the CNS during acute SIV, a parallel approach was used to analyze Nanostring data from the brain (basal ganglia) of the same 6 7d SIV-infected macaques and 8 uninfected controls (2 controls were different animals than those used in the DRG analysis). For the brain data, 4 stably expressed housekeeping genes (GAPDH, rpS9, ACTB, and RPL13A) were used for normalization, and 40 genes were excluded from analyses due to low detection level (primarily cytokines and chemokines).
Protein Isolation and Western Blotting
Frozen L6 DRG were homogenized in 0.5% NP-40 lysis buffer supplemented with protease and phosphatase inhibitor cocktails (Sigma Aldrich, St. Louis, MO) using a FastPrep bench top homogenizer in 2-mL tubes containing lysing matrix M (MP Biomedicals, Santa Ana, CA). Homogenates were then sonicated (3 times for 10 seconds) and centrifuged to remove insoluble material. Protein concentration was estimated using the BioRad Protein Assay Kit (BioRad Laboratories, Hercules, CA) according to manufacturer instructions. Five micrograms of protein were resolved under reducing conditions using 26-well 10% Bis-Tris gels (BioRad) and 1X MOPS buffer. Proteins were transferred to polyvinylidene fluoride membranes, which were subsequently blocked in Trisbuffered saline Tween-20 (TBST) containing 5% nonfat dry milk. Membranes were then incubated with primary against glutaminase ([GLS], rabbit monoclonal; Abcam, Cambridge, UK), glutamine synthetase ([GS], rabbit polyclonal, Abcam), superoxide dismutase-2 ([SOD2], rabbit polyclonal; Abcam), bIII tubulin (clone 5G8; Promega), and b-actin (clone AC-15; Sigma), followed by horseradish peroxidase-conjugated secondary antibodies (goat anti-rabbit IgG and goat anti-mouse IgG; Dako, Carpinteria, CA). Membranes were then washed in TBST and developed with Pierce ECL Western Blotting Substrate (Thermo Fisher) prior to exposure to radiography film. Because GS, bIII tubulin, and b-actin have similar molecular weights, the membranes were first probed for GS, stripped using Restore PLUS Western Blot Stripping Buffer (Thermo Fisher) for 15 minutes at room temperature, then reprobed for bIII-tubulin, followed by b-actin. Films were digitally scanned, and densitometry analysis was performed using ImageQuant TL 7.0 software (GE Life Sciences, Marlborough, MA). To account for blot-to-blot variation, a standard DRG lysate was included in each blot for normalization and b-actin expression was utilized as an in-lane loading control.
Immunohistochemistry
Indirect, peroxidase-based immunostaining was performed on Streck-fixed sections of L5 DRG from 3 control and 6 7d SIV-infected animals using the Leica Bond-Max automated system (Leica Biosystems). The protocol for all antigens included pretreatment with Bond TM Epitope Retrieval 2 and heating for 20 minutes, and positive immunoreactivity was visualized by labeling with 3,3 0 -diaminobenzidine (DAB) chromogen. The same primary antibodies against GLS, GS, and SOD2 were used for immunohistochemistry (IHC) and Western blotting. Isotype-matched nonspecific immunoglobulins were employed as negative controls and showed no significant staining in DRG tissue.
Statistics
Group comparisons between uninfected and 7d SIV animals were performed using the Mann-Whitney test. For Nanostring gene expression data, the Benjamini-Hochberg (BH) correction was applied to correct for multiple comparisons, with the false discovery rate set at 0.05. Correlation between continuous variables was calculated using the Spearman correlation coefficient. Statistical analyses were conducted using Prism software (GraphPad, v7.0b), except for the BH correction, which was applied using the p.adjust function in R (RStudio, v1.1.419). p Values less than or equal to 0.05 were considered significant.
RESULTS
Quantification of DRG mRNA Expression by Nanostring Analysis
After correcting for multiple comparisons, 47 genes showed significant differential expression between uninfected macaques and 7d SIV-infected animals. The Table lists a subset of these genes grouped by function, along with their corresponding adjusted p values (Mann-Whitney with BH correction) and median fold change. A complete list of genes included in the analyses can be found in Supplementary Data Table S1 .
Immune Signaling and Antiviral Responses
During the acute phase of HIV and SIV infection, high levels of plasma viremia are accompanied by an intense systemic cytokine cascade that is thought to contribute to immunopathologic consequences of infection (25, 26, 36) . However, little is known about immune responses occurring in the PNS during acute HIV/SIV infection or the role that such responses could play in early sensory nerve injury. Nanonstring gene expression analysis of RNA isolated from the DRG of 7d SIV-infected macaques revealed significant upregulation of many genes involved in immune activation and early antiviral responses. Many genes with the strongest degree of upregulation (based on median fold change [FC] of 7d SIV-infected group compared to controls) were those involved in type I IFN signaling, including IRF7, IRF1, STAT1, and STAT2, as well as the type I IFN-stimulated genes CCL8, CXCL10, CXCL11, and MX1. Expression of the IFNB gene itself (IFNB1) was also significantly upregulated in the DRG at 7d post-SIV infection (p ¼ 0.002), while IFNa gene expression was not significantly different from controls (p ¼ 0.79). While some type II IFN-stimulated genes, including CXCL9 and IL18BP, were upregulated in the DRG during acute SIV infection, there was no corresponding increase in IFNc gene expression within the DRG (p ¼ 0.89). RNA levels for two key host restriction factors involved in innate antiviral immunity, APOBEC3G and SAMHD1, were also significantly upregulated in the DRG of 7d SIV-infected macaques (p ¼ 0.002 and p ¼ 0.011, respectively).
Macrophage and Satellite Glial Cell Activation
Non-neuronal cells normally present within DRG-satellite glial cells and interstitial macrophages-are immuneresponsive cells that can undergo activation and produce proinflammatory mediators. In the DRG of 7d-SIV-infected macaques, we found a significant increase in GFAP expression (p ¼ 0.007) indicative of satellite glial cell (SGC) activation and/or proliferation, as well as multiple markers of monocyte/ macrophage activation including CD16 (p ¼ 0.005), CD68 (p ¼ 0.002), and CD163 (p ¼ 0.002). There was significantly elevated expression of TNFa (p ¼ 0.007) and CSF1 (p ¼ 0.002), proinflammatory cytokines that stimulate macrophage activation. Expression of CCR5, a chemokine receptor that acts as an HIV and SIV coreceptor on monocytes and macrophages was also significantly increased in the DRG of 7d SIVinfected macaques (p ¼ 0.007), along with its proinflammatory ligand CCL5 (p ¼ 0.002), also known as regulated on activation, normal T cell expressed and secreted (RANTES). There was no significant increase in gene expression of the T-lymphocyte markers, CD3, or CD8 in the DRG at 7d post-SIV expression (p ¼ 0.222 and 0.309, respectively). These results indicate that there is local immune activation of SGCs and macrophages in the DRG at 7 days post-SIV-infection, a time point that precedes detectable DRG macrophage activation by CD68 IHC and significant loss of ENFD (23) . Furthermore, these cells are likely responsible for the upregulation of many of the genes involved in immune signaling and the innate antiviral response.
Glutamate Metabolism and Oxidative Stress
Previous studies have proposed that altered glutamate homeostasis and increased oxidative stress contribute to neuronal damage in the brain during HAND (28) (29) (30) (31) . Thus, to investigate potential mechanisms of early sensory nerve damage in the SIV model, we evaluated the expression of genes related to glutamate metabolism and the oxidative stress response in the DRG of acutely infected and control animals. Nanostring analysis revealed that among 9 genes related to glutamate metabolism, glutamine synthetase (GS), and glutaminase (GLS), were differentially expressed between control and 7d SIVinfected macaques. GS was significantly upregulated in the 7d SIV-infected animals (p ¼0.011), whereas GLS expression was significantly downregulated (p ¼ 0.004).
To assess induction of an oxidative stress response in the DRG, we focused on the gene expression of 27 enzymes involved in the production and detoxification of reactive oxygen species (ROS). Two genes in this group, superoxide dismutase-2 (SOD2) and glutaredoxin (GLRX), were significantly upregulated in the 7d SIV-infected macaques (both with p ¼ 0.002). Five oxidative stress response genes were significantly downregulated: copper chaperone for SOD (CCS, p ¼ 0.004), glutathione peroxidase 4 (GPX4, p ¼ 0.043), glutathione reductase (GSR, p ¼ 0.002), peroxiredoxin 2 (PRDX2, p ¼ 0.003), and peroxiredoxin 3 (PRDX3, p ¼ 0.001). Of the oxidative stress response genes examined, SOD2, which encodes the mitochondrial isoform of super oxide dismutase, had the greatest median fold change in 7d SIVinfected animals compared to the control group (median FC ¼ 1.60, Table) . In addition, when Nanostring data was compared to previously published foot-pad ENFD values for the 7d SIVinfected group (23), SOD2 was the only gene on the panel whose expression in the DRG significantly correlated with ENFD among 7d-SIV-infected macaques (p ¼ 0.0167, r ¼ À0.9429; data not shown). There was no significant difference in gene expression of the cytoplasmic SOD1 or extracellular SOD3 isoforms of superoxide dismutase between the control and 7d SIV groups.
Comparison to the CNS
Nanostring analysis of RNA isolated from the basal ganglia of the brain showed that, similar to the DRG, acute SIV infection is associated with robust upregulation of many genes involved in interferon signaling including IFNB1, IRF1, IRF7, MX1, STAT1, and STAT2, as well macrophage/microglial activation marker CD68 and SIV/HIV coreceptor CCR5. This is in line with previous findings of acute SIV in the CNS (37) . However, in contrast to the DRG, there was no significant increase in expression of GFAP or changes in genes related to glutamate metabolism or oxidative stress in the basal ganglia of 7d SIV-infected macaques compared to uninfected controls (Supplementary Data Table S2 ) demonstrating PNS-specific acute alterations independent of CNS changes.
Quantification of DRG Protein Expression by Western Blot
To further investigate significant novel findings from the RNA analyses at the protein level, Western blots were performed to measure expression of GLS, GS, and SOD2 in DRG homogenates. Densitometry results were normalized to the pan-cellular loading control, b-actin. bIII tubulin was also included as a neuron-specific protein.
As shown in an image of a representative blot (Fig. 1) and graphically ( Fig. 2) , there were no significant differences in the amounts of GLS (p ¼ 0.573, Fig. 2A ) or GS expression (p ¼ 0.228, Fig. 2C ) in the DRG of 7d SIV-infected animals compared to controls. In contrast, the relative amount of SOD2 expression in the DRG was elevated in 7d SIV-infected animals (p ¼ 0.001, Fig. 2C ), which is in accordance with the RNA expression data. bIII tubulin protein levels in the DRG were significantly and consistently decreased at 7 days post-SIV infection when normalized to b-actin (p < 0.001, Fig. 3A) . At the RNA level, the encoding bIII tubulin (TUBB3) was downregulated in the 7d SIV-infected group prior to adjusting for multiple comparison (p ¼ 0.043, Fig. 3B) , with a median FC of À1.52 compared to uninfected controls; however, this was not significant after BH correction (p ¼ 0.079).
Immunohistochemistry
We performed immunostaining on fixed sections of L5 DRG from control and 7d SIV-infected macaques to identify which cell types in the ganglia express GLS, GS, and SOD2 in normal conditions, and to determine whether the amount of expression or cell specificity change during acute SIV infection. GLS expression in both control and 7d SIV-infected animals was primarily restricted to the neurons, with diffuse, moderate to strong cytoplasmic staining of the neuronal cell bodies (Fig. 4A, B) . Scattered interstitial cells, likely macrophages, also showed light cytoplasmic reactivity for GLS in both control and 7d SIV-infected ganglia. In uninfected animals, GS expression in the DRG was most apparent in the SGCs, with little to no staining in the neuron cell bodies (Fig. 4C) . In contrast, all 7d SIV-infected ganglia exhibited moderate GS expression in the cytoplasm of neuron cell bodies (Fig. 4D) . Furthermore, this increase in neuronal GS expression was primarily observed in small-to medium-sized neuronal cell bodies, a population which is thought to represent nociceptive neurons (38) . SOD2 immunostaining demonstrated diffuse, light to moderate cytoplasmic staining in all cell types in the DRG, with a finely stippled pattern consistent with mitochondrial localization (Fig. 4E) . In 7d SIV-infected ganglia there was an increase in the intensity of SOD2 immunostaining, which localized primarily to the SGCs and interstitial macrophage-like cells (Fig. 4F) .
DISCUSSION
Previous work in the pigtailed macaque model of HIV-SN has demonstrated that DRG macrophage activation and ENFD decline were detectable 14 days post-SIV inoculation, immediately following the acute phase of infection, and that this loss of ENFD persisted in cART-treated SIV-infected animals despite viral suppression and normalization of CD68 immunostaining in the DRG (23) . The aims of this study were to gain a more detailed understanding of molecular alterations in the PNS during acute SIV infection, thereby informing future studies aimed at preventing or reversing sensory nerve damage in HIV patients.
Nanostring analysis of lumbar DRG collected from animals at 7 days post-SIV inoculation revealed that acute infection is associated with significant local upregulation of genes involved in interferon signaling, which has been shown to play a major role in the innate antiviral responses to both SIV and HIV infection (25, 26, 37, (39) (40) (41) , as well as multiple markers of macrophage activation and proinflammatory cytokines and chemokines. Some of the immune mediators upregulated in the DRG during acute SIV infection have been previously implicated in the pathogenesis of sensory neuropathy and neuropathic pain. For example, TNFa has been linked to the development of HIV-SN in multiple rodent models of the disorder, as well as genetic analyses of certain HIV patient populations (42) (43) (44) , and is one of the neurotoxic mediators released by macrophages upon binding of CCR5 by the HIV gp120 protein (45) . Furthermore, inhibition of CCR5 signaling by the CCR5 antagonist maraviroc resulted in decreased glial activation and pain behaviors in a rat model of neuropathic pain (46) . In a CD8 lymphocyte-depleted rhesus macaque model of HIV-SN, a significant increase in the number of CCR5-positive cells were found in the DRG of SIV-infected animals at terminal time points compared to uninfected controls, and plasma levels of the CCR5 ligand CCL5/RANTES inversely correlated with ENFD at matched time points through infection. The fact that we detected increased gene expression of CCR5 and CCL5 in the DRG at 7 dpi suggests that early treatment with maraviroc may decrease sensory neuron damage in HIV patients.
While it is feasible that immune-related factors alone could account for neuronal damage during early HIV/SIV infection, we were also interested in other neurotoxic mechanisms induced during acute disease, as these could provide targets for neuroprotective therapies. Excitoxic injury due to altered glutamate handling has been implicated in the pathogenesis of HAND, and while there has been much interest in targeting this system therapeutically, such approaches are complicated by the broad role of glutamate in the CNS (29, 31) . Recently, glutamate has also been shown to act as an important neuroglial signaling molecule in the PNS, and may impact pain signaling at the level of the sensory ganglia (47) (48) (49) . Nanostring analysis of DRG RNA from 7d SIV-infected macaques revealed significant downregulation of the gene encoding the glutaminase enzyme (GLS), which catalyzes the deamination of glutamine to form glutamate. This was surprising based on previous work showing increased GLS mRNA in HIV-infected macrophages and microglia (50) (51) (52) and that glutamate is a key factor in macrophage-mediated neurotoxicity in vitro (53, 54) . This discrepancy could be related to the fact that GLS expression was measured at the whole tissue level in this study, rather than isolated macrophages. Neuronal cell bodies make up a much larger proportion of the DRG tissue than macrophages and contain abundant GLS protein (as shown by the IHC). Thus, total GLS RNA levels in the DRG are likely more reflective of neuronal GLS expression than that of the interstitial macrophages. We suspect that decreased neuronal GLS expression could be a compensatory response to increased extracellular glutamate levels in the DRG.
In contract to GLS, expression of the gene encoding GS, the enzyme that converts glutamate to glutamine, was significantly increased in the DRG during acute SIV infection. IHC showed that GS protein predominantly localized to SGCs in the DRG of uninfected macaques with minimal to no appreciable staining in the neuronal cell bodies. This is in line with previous IHC studies of the DRG (55) and is similar to the CNS where GS is restricted to astrocytes under normal conditions (56). During acute SIV, however, we observed increased GS immunoreactivity within neuronal cell bodies. Neuronal GS expression represents a novel finding in the PNS. In studies of the CNS, GS immunoreactivity has been observed in pyramidal neurons of patients with advanced Alzheimer disease, likely due to marked impairment of normal glutamate handling by nearby astrocytes (56, 57) . Similarly, cultured rat cerebellar neurons express higher levels of GS when deprived of extracellular glutamine and direct contact with astrocytes (58) . Together, these observations underscore the importance of glutamine as an essential metabolite for neuronal cells and suggest that, when the normal source of glutamine is diminished or absent, neurons can upregulate GS to meet their metabolic needs. In the setting of the DRG, neuronal expression of GS may reflect depletion of the extracellular glutamine pool by non-neuronal cells undergoing SIV-induced immune activation or altered glutamate handling by SGCs. In either case, neuronal GS expression likely represents a profound shift in metabolic balance within the DRG, which could directly contribute to sensory nerve dysfunction and damage during acute SIV infection. Changes in GLS and GS gene expression were not significantly reflected by Western blot analysis. However, it is possible that this technique lacked the sensitivity to detect subtle changes in total protein levels in the DRG tissue, or that the assay was statistically underpowered due to small group size. It is also possible that changes at the RNA level were not propagated to significant protein changes.
Similar to glutamate excitotoxicity, production of excess ROS in the brain has been shown to be a potential source of neuronal damage in HAND (28, 30) . Elevated levels of oxidative modifications and mitochondrial ROS (mROS) production have also been detected in the peripheral nerves of HIV patients with PN as well as SIV-infected pigtailed macaques with diminished ENFD (59) . Several genes related to the oxidative stress response were differentially regulated in the DRG during acute SIV infection compared to uninfected controls. Because of the well-established role of mitochondrial alterations in HIV-SN, we chose to focus on the mitochondrial isoform of superoxide dismutase, SOD2, which was significantly upregulated at both the RNA level and the protein level. Furthermore, although the median foot-pad ENFD of the 7d SIV-infected group was not significantly lower than that of the control group (23), SOD2 gene expression in the DRG showed significant, inverse correlation with ENFD values among 7d-SIV-infected macaques, suggesting a relationship between increasing SOD2 expression and early ENFD loss. We initially hypothesized that enhanced SOD2 protein expression would primarily localize to the neuron cell bodies in the DRG; however, while there was a clear increase in the intensity of SOD2 staining in 7d SIV-infected animals, it predominantly aligned with SGCs and interstitial macrophages. One explanation for this finding would be that enhanced SOD2 expression is an adaptive response to increased mROS production by cells undergoing immune activation. This phenomenon has been explored in macrophages and microglia, where production of mROS has been shown to augment immune signaling and cytokine production (60, 61) . In addition, our finding that multiple oxidative stress response genes were significantly downregulated in the DRG of 7d SIV-infected macaques suggests that protective mechanisms in the DRG may be dysregulated during acute infection and insufficient to mitigate ROSinduced neuronal injury.
Another unexpected finding in this study was the consistently decreased level of the neuron-specific microtubule protein, bIII tubulin, in the DRG of acutely infected macaques. It is unlikely that this finding reflects overt neuronal loss in the DRG, which in only evident during late stages of disease in this SIV/macaque model (62) . Rather, this finding may reflect increased transport of bIII tubulin from the neuron cell body into the axon to support axonal regeneration. This phenomenon has been demonstrated in a rat model of peripheral nerve injury, wherein bIII tubulin mRNA and protein levels were decreased in the DRG at 1 day post-axotomy, followed by robust increase in the DRG and proximal axons after 1 week (63, 64) . We hope to further investigate the mechanism underlying this finding in future studies.
When comparing gene expression changes in the DRG of 7d SIV-infected macaques with brain tissue, specifically the basal ganglia, we found that although there was similar marked upregulation of genes involved in the early immune response, there were no significant alterations in genes related to glutamate metabolism or oxidative stress in the brain at this acute time point. Whether these findings represent specific differences in neuronal versus non-neuronal cell populations in these tissues (satellite glial cells vs astrocytes, interstitial macrophages vs microglia) or the fact that the DRG is not protected by the blood-CNS barrier or blood-nerve barrier (65) remains to be determined. In either case, this finding suggests that the PNS is more susceptible to metabolic alterations than the CNS during acute SIV infection and that the mechanisms underlying early neuronal damage in the PNS and CNS may differ.
This investigation represents the first comprehensive molecular analysis of the DRG during acute SIV infection. Although limited by factors inherent to macaque studies, such as cross-sectional design, our findings provide valuable insights into the origins of sensory nerve dysfunction in HIV. The recognition of the DRG as a site of marked local immune activation and potentially neurotoxic metabolic alterations during acute infection, prior to the onset of significant neuropathology or neurophysiologic alterations, will inform future studies on the pathogenesis of HIV-SN in the macaque model. Because managing HIV-SN is extremely challenging once neuropathic symptoms are established, effective approaches for preventing sensory nerve damage early are urgently needed. A fuller understanding of neuropathologic mechanisms induced in the PNS during early HIV infection holds promise for elucidating neuroprotective strategies.
